Literature DB >> 133356

Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.

L J Herberg, D N Stephens, K B Franklin.   

Abstract

Investigation of the role of noradrenaline (NA) and dopamine (DA) in self-stimulation showed that d-amphetamine (which releases more DA than does l-amphetamine, but not more NA) was much more effective than l-amphetamine in enhancing self-stimulation of NA sites in the locus coeruleus and near-lateral hypothalamus. In DA sites in the substantia nigra and far-lateral hypothalamus the effects of the 2 isomers were confirmed to be more nearly equal. Thymoxamine HCl (10 mg/kg IP), a specific alpha-adrenergic receptor blocker, depressed self-stimulation at all sites, but significantly more severely at DA sites. Thus the drugs most effective in influencing self-stimulation at a particular site were those acting predominantly on the unstimulated system. These findings were interpreted in terms of a hypothesis that DA and NA play complementary roles in self-stimulation and that both are essential; or, more specifically, that DA pathways, implicated in other motivational activites, contribute to a state of drive or arousal necessary for self-stimulation; while response-contingent noradrenergic activity (elicited by the electrodes directly via a transsynaptic route) mediates reinforcement. Further predictions from this hypothesis were tested as follows: (1) Direct pharmacological stimulants of adrenergic alpha-receptors should disrupt self-stimulation by acting randomly on the reinforcement system and disrupting response-reward contingencies; this was confirmed by the finding that the alpha-receptor stimulant clonidine HCl (0.05 mg/kg) depressed self-stimulation at all sites tested. (2) Drect stimulants of DA receptors should enhance self-stimulation of NA sites by augmenting dopaminergic motivational activity; but in rats with DA electrodes, noncontingent stimulation of DA receptors would also impose similar noncontingent activity on the transsynaptic noradrenergic reinforcement pathways and thus depress self-stimulation; this was confirmed by the finding that apomorphine (0.3-1.0 mg/kg) was strongly stimulant for NA electrodes but strongly depressant for DA electrodes, and that the degree and direction of these effects was highly correlated with the differential effects of d- l-amphetamine (rho = .65, p less than 0.01). Neither effect of apomorphine depended on the occurrence of motor stereotypy. These results can be interpreted in terms of 2-component models for self-stimulation, with the predominant transmitter of the drive component being identified as DA and that g the reinforcing component as NA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 133356     DOI: 10.1016/0091-3057(76)90200-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Inhibition-mediating dopamine receptors and the control of intracranial reward.

Authors:  R J Katz
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

2.  Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs.

Authors:  A Delini-Stula; P Baumann; O Büch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

3.  Specific neural correlates of successful learning and adaptation during social exchanges.

Authors:  Adam P R Smith-Collins; Chiara Fiorentini; Esther Kessler; Harriet Boyd; Fiona Roberts; David H Skuse
Journal:  Soc Cogn Affect Neurosci       Date:  2012-09-05       Impact factor: 3.436

4.  Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.

Authors:  R Depoortere; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

5.  The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.

Authors:  L J Herberg; I C Rose
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Effects on hypothalamic self-stimulation of drugs influencing dopaminergic neurotransmission injected into nucleus accumbens and corpus striatum of rats.

Authors:  D N Stephens; L J Herberg
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

Review 7.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

8.  Brain site variations in effects of morphine on electrical self-stimulation.

Authors:  W T Nelson; S S Steiner; M Brutus; R Farrell; S J Ellman
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.

Authors:  John F Cryan; Adrie W Bruijnzeel; Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-16       Impact factor: 4.530

10.  The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission.

Authors:  A M Montgomery; I C Rose; L J Herberg
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.